|
|
|
|
|
doxorubicine aktief product
|
|
Euro €56,28
|
|
|
|
|
|
|
|
doxorubicine aktief product
|
|
Euro €16,82
|
|
|
|
|
|
|
|
doxorubicine aktief product
|
|
Euro €56,28
|
|
|
|
|
|
|
|
doxorubicine aktief product
|
|
Euro €258,80
|
|
|
|
|
|
|
|
aktief product
|
|
|
|
|
|
|
|
|
|
aktief product
|
|
|
|
|
|
|
|
|
|
cytarabine UIT DE HANDEL
|
|
Euro €28,36
|
|
|
|
|
|
|
|
cytarabine UIT DE HANDEL
|
|
Euro €33,88
|
|
|
|
|
|
|
|
cytarabine UIT DE HANDEL
|
|
Euro €55,50
|
|
|
|
|
|
|
|
cytarabine UIT DE HANDEL
|
|
Euro €25,86
|
|
|
|
|
|
|
|
cytarabine UIT DE HANDEL
|
|
Euro €27,05
|
|
|
|
|
|
|
|
cytarabine UIT DE HANDEL
|
|
Euro €41,84
|
|
|
|
|
|
|
|
pemetrexed aktief product
|
|
|
|
|
|
|
|
|
|
melfalan aktief product
|
|
Euro €12,77
|
|
|
|
|
|
|
|
melfalan UIT DE HANDEL
|
|
Euro €27,76
|
|
|
|
|
|
|
|
melfalan aktief product
|
|
Euro €10,18
|
|
|
|
|
|
|
|
amsacrine aktief product
|
|
Euro €230,14
|
|
|
|
|
|
|
|
nelarabine aktief product
|
|
Euro €2185,99
|
|
|
|
|
|
|
|
bevacizumab aktief product
|
|
Euro €363,72
|
|
|
|
|
|
|
|
bevacizumab aktief product
|
|
|
|
|
|
|
|
|
|
bleomycine aktief product
|
|
Euro €18,96
|
|
|
|
|
|
|
|
bleomycine aktief product
|
|
Euro €23,70
|
|
|
|
|
|
|
|
aktief product
|
|
|
|
|
|
|
|
|
|
? aktief product
|
|
|
|
|
|
|
|
|
|
doxorubicine aktief product
|
|
|
|
|
|
|
|
|
|
doxorubicine aktief product
|
|
Euro €519,36
|
|
|
|
|
|
|
|
irinotecan aktief product
|
|
Euro €47,58
|
|
|
|
|
|
|
|
irinotecan aktief product
|
|
Euro €108,02
|
|
|
|
|
|
|
|
irinotecan aktief product
|
|
|
|
|
|
|
|
|
|
carboplatine UIT DE HANDEL
|
|
Euro €243,27
|
|
|